Eurofins acquires India-based preclinical CRO

By Melissa Fassbender contact

- Last updated on GMT

Eurofins is a laboratory and analytical testing services provider. (Image: iStock/macgyverhh)
Eurofins is a laboratory and analytical testing services provider. (Image: iStock/macgyverhh)
Eurofins Scientific has acquired the India-based preclinical CRO Advinus Therapeutics after raising €650m.

Eurofins signed a definitive agreement with individual shareholders of Advinus Therapeutics and Tata Sons, Tata Industries, and Rallis India.

Advinus is a preclinical CRO providing safety assessment, CMC, DMPK, and analytical research and development services. The company operates a 20,000 sq meter facility in Bangalore, India.

The transaction, terms of which have not been disclosed, is expected to close in the next several weeks.

Advinus has substantial capabilities that are in synergy with Eurofins and provide us with additional opportunities to grow the company​,” Rajiv Malik, Advinus CEO, commented in the press release.

The acquisition follows an announcement that Eurofins successfully raised €650m ($759.17m) in its most recent senior unsecured Euro bond public issuance.

The proceeds will be used for general corporate purposes, including debt refinancing, as well as to fund “any further growth opportunity in-line with the Group’s strategy and objectives​,” according to the company.

Dr. Gilles Martin, Eurofins CEO commented in the release that the bond strengthens the company’s ability “to respond swiftly to compelling opportunities​” – following good market conditions and strong M&A activity this year, he added.

As previously​ reported, Eurofins also acquired the drug ingredient manufacturing and testing services firm Alphora Research in June. The deal adds two facilities to Eurofin’s network of drug testing laboratories.

Eurofins did not respond to a request for comment.

Related news

Show more

Related products

show more

Flexible Filling Solution for CMOs

Flexible Filling Solution for CMOs

Single Use Support GmBH | 18-May-2022 | Insight Guide

Achieving flexibility requires modularity of technologies.

CMOs and CDMOs aspire to be flexible for multiple applications. Efficient automated...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Related suppliers

Follow us


View more